Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFE

Pfizer Inc

Sep 15 • 02:34PM ET

23.88

+0.00 0.02 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT COWZ DVY

Scroll to Statements

Index	S&P 500	P/E	12.69	EPS (ttm)	1.88	Insider Own	0.12%	Shs Outstand	5.68B	Perf Week	-2.75%
Market Cap	135.74B	Forward P/E	7.57	EPS next Y	3.16	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	-4.92%
Enterprise Value	184.61B	PEG	105.76	EPS next Q	0.72	Inst Own	66.97%	Short Float	1.82%	Perf Quarter	-2.71%
Income	10.73B	P/S	2.13	EPS this Y	-0.48%	Inst Trans	-0.69%	Short Ratio	2.50	Perf Half Y	-7.17%
Sales	63.83B	P/B	1.53	EPS next Y	1.95%	ROA	5.08%	Short Interest	103.47M	Perf YTD	-10.01%
Book/sh	15.60	P/C	10.25	EPS next 5Y	0.12%	ROE	12.16%	52W High	30.43 -21.54%	Perf Year	-19.50%
Cash/sh	2.33	P/FCF	10.91	EPS past 3/5Y	-28.65% -13.25%	ROIC	7.34%	52W Low	20.92 14.15%	Perf 3Y	-49.29%
Dividend Est.	1.71 (7.15%)	EV/EBITDA	7.19	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	67.34%	Volatility	2.03% 1.71%	Perf 5Y	-29.88%
Dividend TTM	1.71 (7.16%)	EV/Sales	2.89	EPS Y/Y TTM	511.13%	Oper. Margin	29.60%	ATR (14)	0.47	Perf 10Y	-19.69%
Dividend Ex-Date	Jul 25, 2025	Quick Ratio	0.85	Sales Y/Y TTM	14.72%	Profit Margin	16.81%	RSI (14)	39.51	Recom	2.50
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.16	EPS Q/Q	11938.10%	SMA20	-4.02%	Beta	0.51	Target Price	28.50
Payout	119.94%	Debt/Eq	0.70	Sales Q/Q	10.31%	SMA50	-3.63%	Rel Volume	1.10	Prev Close	23.87
Employees	81000	LT Debt/Eq	0.65	Earnings	Aug 05 BMO	SMA200	-4.11%	Avg Volume	41.43M	Price	23.88
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	34.39% 8.06%	Trades		Volume	36,073,445	Change	0.02%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 01:07PM	CDC vaccine panel to meet this week: Here's what's at stake (CNBC TV)
10:27AM	CorMedix Rallies 60% YTD: Is This an Indication to Buy the Stock? (Zacks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:56AM	COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths (Zacks)
06:55AM	How Bad Is This Sector's Health Scare? (The Wall Street Journal)
01:56PM	Loading…
Sep-13-25 01:56PM	Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths (FastCompany)
04:00AM	1 Reason Every Investor Should Know About Pfizer (PFE) Stock (Motley Fool)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
07:55PM	Review & Preview: Waiting for the Rate Cut (Barrons.com)
07:43PM	Drugmakers Fall on Report US to Claim Covid Shot Killed Kids (Bloomberg)
04:21PM	Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
04:00PM	Why Pfizer (PFE) Shares Are Sliding Today (StockStory)
02:56PM	Vaccine Stocks Fall on Reports FDA Will Allege Link Between Covid-19 Shots and Child Deaths (Barrons.com)
02:11PM	Vaccine Stocks Down Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
01:37PM	COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says (MarketWatch)
12:33PM	Loading…
12:33PM	Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths (Investing.com)
12:11PM	Trump officials to link child deaths to COVID shots, Washington Post reports (Reuters)
11:35AM	Stock Market Today: Investors await opening trade from Gemini, Via, and Legence (TheStreet)
10:38AM	OLMA Stock Soars 47% in September So Far on Second PFE Deal (Zacks)
10:25AM	Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects (Zacks)
09:08AM	BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? (Zacks)
03:00AM	Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl (Barrons.com)
Sep-11-25 05:45PM	Why Pfizer (PFE) Outpaced the Stock Market Today (Zacks)
12:49PM	Pfizer (PFE) and BioNTech SE Announce Positive Topline Results From an Ongoing Phase 3 Clinical Trial (Insider Monkey)
11:20AM	Pfizer (PFE), Astellas Post Favorable Trial Results for Bladder Cancer Combo (Insider Monkey)
09:52AM	Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? (Zacks)
04:25AM	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novartis, Pfizer and Bayer (Zacks)
Sep-10-25 03:55PM	China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order (Investor's Business Daily)
12:12PM	Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales. (Barrons.com)
11:08AM	5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds (Zacks)
11:02AM	Loading…
11:02AM	J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum (Zacks)
05:17AM	Pfizer-Olema Collaboration Targets Metastatic Breast Cancer (Insider Monkey)
Sep-09-25 08:00PM	Health Officials Hunt for Cases Connecting Covid Shot and Harm in Pregnant Women (The Wall Street Journal)
06:48PM	A Lyme Disease Vaccines Final Test Results Could Appear By Yearend. (Barrons.com)
11:21AM	Will LLY's Oncology Portfolio Provide Key Diversification Benefits? (Zacks)
08:50AM	Will Merck's Cost Cuts and New Drug Approvals Ease Headwinds? (Zacks)
06:37AM	Crypto Stock Market Gambles Are Paying Off. Why That Luck Won't Last. (Barrons.com)
Sep-08-25 01:41PM	Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective (Barrons.com)
10:15AM	Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth? (Zacks)
09:42AM	Investing in Oncology: 3 Cancer Stocks With Promising Pipelines (Zacks)
09:15AM	J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned? (Zacks)
06:45AM	Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula (Business Wire)
Sep-07-25 10:23AM	Pfizer Inc (PFE) Announces New Trial Collaboration With Olema Pharmaceuticals (Insider Monkey)
09:30AM	Is Pfizer a Millionaire Maker? (Motley Fool)
Sep-05-25 12:22PM	Analyst Report: BioNTech SE (Morningstar Research)
10:27AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
Sep-04-25 03:00PM	Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity? (Zacks)
07:53AM	2 Top Dividend Stocks to Buy With Less Than $50 (Motley Fool)
06:45AM	3 Things You Need to Know if You Buy Pfizer Today (Motley Fool)
Sep-03-25 11:19AM	Pfizer defends Covid-19 vaccine effectiveness after Trump remarks (CNBC TV)
10:58AM	Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize (Bloomberg)
10:04AM	J&J Gears Up for Some Key New Drug Approvals and Launches (Zacks)
Sep-02-25 04:25PM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
10:18AM	Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path? (Zacks)
09:07AM	Is Pfizer Stock Underperforming the Nasdaq? (Barchart)
04:00AM	How AI advances will shape the drugmaker of the future (Pharma Voice)
03:28AM	Pfizer Inc. (PFE)'s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide (Insider Monkey)
03:21AM	3 High-Yield Dividend Stocks You Can Buy in September and Hold Forever (Motley Fool)
Sep-01-25 11:59AM	Pfizer's Golden Cross Signals Strength: How to Play the Stock (Zacks)
06:00AM	Pfizer's 7% Dividend: Income Gem or Value Trap? (Motley Fool)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)
06:45AM	3 No-Brainer Stocks to Buy Right Now (Motley Fool)
12:10AM	Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine (Insider Monkey)
Aug-30-25 08:45AM	4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer (Motley Fool)
05:45AM	Better High-Yielding Dividend Stock: Realty Income vs. Pfizer (Motley Fool)
Aug-29-25 11:51AM	Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Aug-28-25 05:07PM	Inside the Trump Administrations Vaccine Politics (The Wall Street Journal)
12:04PM	FDA Approves Updated COVID-19 Vaccines but With Restrictions (Zacks)
11:13AM	MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate (Zacks)
10:10AM	Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum? (Zacks)
09:22AM	Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds? (Zacks)
07:55AM	FDA approves mRNA vaccines for new Covid-19 season amid political tension (Pharmaceutical Technology)
03:49AM	Analyst Report: Pfizer Inc. (Morningstar Research)
12:47AM	Morgan Stanley Lifts Pfizer (PFE) Price Target, Keeps Equalweight Rating (Insider Monkey)
Aug-27-25 11:35PM	Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q2 (StockStory)
02:30PM	RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. (Investor's Business Daily)
01:56PM	FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use (Barrons.com)
01:42PM	New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. (The Wall Street Journal)
01:30PM	Unusual Put Option Activity in Pfizer Stock - Have Investors Turned Bearish? (Barchart)
12:50PM	Pfizer and BioNTechs COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 (Business Wire)
10:05AM	Will Camzyos Strengthen BMY's Cardiovascular Portfolio? (Zacks)
09:45AM	My 3 Favorite Stocks to Buy Right Now (Motley Fool)
08:08AM	LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors? (Zacks)
Aug-26-25 08:31PM	Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' (Benzinga)
09:40AM	GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU (Zacks)
Aug-25-25 10:41PM	Asian shares decline following Wall Street's dip (Associated Press Finance)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
01:22AM	Stocks slip on Wall Street after last week's rally (Associated Press Finance)
Aug-23-25 06:45AM	3 Unstoppable Dividend Stocks to Buy Right Now (Motley Fool)
Aug-22-25 04:27PM	Top Analyst Reports for NVIDIA, Cisco & Linde (Zacks)
09:39AM	AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth (Zacks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:43AM	ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth (Zacks)
08:00AM	Investors Crave Long-Term Debt, But Firms Dont Want to Sell (Bloomberg)
04:35AM	My 5 Favorite Stocks to Buy Right Now (Motley Fool)
Aug-21-25 01:14PM	Latest Fed cut signals, pharma relief rally, Apple TV+ price hike (Yahoo Finance Video)
01:04PM	Padcev-Keytruda combo approved for NHS use in mUC (Pharmaceutical Technology)
11:32AM	US-EU trade deal impacts on pharma industry more 'manageable' than expected (Yahoo Finance)
11:21AM	Low Volatility Calls For This Breakout Trade On Pfizer Stock (Investor's Business Daily)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience